Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 3.335% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CSc1nc2c(c(OC(=O)c3ccccc3Cl)n1)CCCC2
b: COc1ccc(C(=O)Nc2ccc(-c3ccc(NC(=O)c4ccc(OC)cc4)c(OC)c3)cc2OC)cc1
Answer: a. CSc1nc2c(c(OC(=O)c3ccccc3Cl)n1)CCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSc1nc2c(c(OC(=O)c3ccccc3Cl)n1)CCCC2
CSc1nc2c(c(OC(=O)c3ccccc3Cl)n1)CCCC2
(2-methylsulfanyl-5,6,7,8-tetrahydroquinazolin-4-yl) 2-chlorobenzoate